Pfizer applies for booster approval in SA

accreditation
0:00
play article
Subscribers can listen to this article
The Pfizer and BioNTech logo.
The Pfizer and BioNTech logo.
Photo Illustration by Thiago Prudêncio/SOPA Images

Pfizer and BioNTech have applied to have their coronavirus vaccine approved by the South African Health Regulatory Products Authority for use as a booster.

The vaccine, the most widely used in South Africa for initial inoculation against Covid-19, would be the first to be approved for use as a booster in the mass rollout of vaccines to South Africa.

The authority will assess the data to determine “the safety and efficacy” of its use as a third dose, it said in a statement on Monday.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Rand - Dollar
15.88
-0.0%
Rand - Pound
19.77
+0.1%
Rand - Euro
16.78
+0.1%
Rand - Aus dollar
11.14
+0.4%
Rand - Yen
0.12
-0.1%
Gold
1,840.80
-0.1%
Silver
21.87
-0.2%
Palladium
2,013.00
+0.2%
Platinum
962.00
-0.5%
Brent Crude
112.04
+2.6%
Top 40
61,726
0.0%
All Share
68,246
0.0%
Resource 10
71,337
0.0%
Industrial 25
75,802
0.0%
Financial 15
15,729
0.0%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot